S Guan, X Chen, Y Chen, W Xie, H Liang, X Zhu… - Clinical Cancer …, 2022 - AACR
Purpose: Although gefitinib prolonged the progression-free survival (PFS) of patients with
non–small cell lung cancer (NSCLC), unpredictable resistance limited its clinical efficacy …